News and Trends 7 Feb 2023
Certa scleroderma study shows improvement in more than 60% of patients
Certa Therapeutics has announced what it says are ground-breaking clinical trial data for FT011, its novel therapy for the treatment of serious inflammatory and fibrotic diseases. Certa Therapeutics has recently…